Amerika Onkologiya Jamiyatining (ASCO) 2017 yilgi yillik yig'ilishi mahalliy vaqt bilan 2 iyun kuni Chikagoda bo'lib o'tadi. 12-may, mahalliy vaqt bilan soat 17:XNUMX da, ASCO Aleksandriya shtab-kvartirasida LBA tadqiqoti nashri va hisobot jadvalini e'lon qilish uchun yig'ilish oldidan matbuot anjumani o'tkazdi.
Professor Vu Yilongning tadqiqoti (Mavhum 8500)
ASCO raisi professor Xeys va Xou Ren raisi professor Jonson 6 ta tadqiqotni taqdim etdilar va tavsiya qildilar, shular jumlasidandir. Quyida oltita tadqiqotdan birining asosiy mazmuni ABTRACT 3517.
The study used CALGB’s questionnaire of 826 patients in the phase III kolorektal saraton clinical trial in 1999 to analyze o'rtasidagi munosabatlar eating nuts and the xavfi yo'g'on ichak saratoni takrorlanish va o'lim.Tadqiqotning maxsus test natijalari ASCO 2017 yig'ilishida (ABSTRACT 3517) xabar qilinadi.
Asosiy natijalar
2 untsiyadan ko'proq
The results of this observational study showed that patients with yo'g'on ichak saratoni who consumed nuts for one week compared with patients who did not consume nuts,
Ovqatlanadigan yong'oqlarning foydasi ma'lum prognostik omillarga (yosh, BMI, jins, keng tarqalgan genetik mutatsiyalar) va boshqalarga aloqasi yo'q.
Yog'ochli yong'oqlarga bodom, yong'oq, findiq, kaju va yong'oq kiradi.
Tadqiqotning ikkinchi tahlili shuni ko'rsatdiki, yo'g'on ichak saratoni bilan kasallangan bemorlarga foyda keltiradigan yong'oqlar yog'ochli yong'oqlar (daraxt yong'oqlari) bilan cheklangan.
izoh
ASCO raisi Daniel F. Hayes: "Saratonni davolash paytida sog'lom ovqatlanish ko'pincha e'tibordan chetda qoladi. Ushbu tadqiqot shuni ko'rsatadiki, yong'oq kabi narsalar saraton kasalligining natijalariga ham ta'sir qilishi mumkin. Umid qilamizki, kelajakda yo'g'on ichak saratoni tashxisi va davolashda klinisyenlar kasallikni davolash strategiyasi to'g'risida qaror qabul qilganda, sog'lom ovqatlanish omillarini ham hisobga olish kerak. "
Researcher Professor Temidayo pointed out at the press conference: “A number of studies have shown that people with heart disease and diabetes can benefit from taking nuts. We think it is necessary to carry out this trial in cancer patients.
“For advanced patients, the question often asked by doctors is what can they reduce the risk of disease recurrence and death in addition to standard treatment. The concept of benefit from healthy diet and physical exercise advocated by the study is this A blank makes an effective addition. “
“Patients with stage III colorectal cancer have a 3-year survival rate of 70% after surgery, radiotherapy and chemotherapy. Many studies have shown that diet is important for cancer prevention, so we have the idea of conducting this clinical trial.
